Fig. 1 · Structure
Documents & Downloads
Lapiteronel
Cat. No.
A69745
CAS
1260006-20-9
CYP17/CYP11B2 Inhibitor
Lapiteronel is a nonsteroidal, orally active inhibitor of CYP17 and CYP11B2, functioning as a reversible dual inhibitor. This compound exhibits significant biological activity in the modulation of steroid hormone synthesis, making it a valuable tool for research in metastatic castration-resistant prostate cancer. Its role in inhibiting critical enzymatic pathways positions Lapiteronel as a potential therapeutic agent in advancing cancer treatment studies.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 1260006-20-9 |
| Applications | CYP17/CYP11B2 Inhibitor |
| Formula | C14H13ClN4O |
| Molecular Weight | 288.73 |
| Synonyms | CFG920 |
| SMILES | O=C1N(C2=C(C)C=CN=C2)CCN1C3=CC(Cl)=NC=C3 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.